Clincal Outcomes Ans Assessment Of Quality of Life of Patients Diagnosed With Metastatic Renal Cell Carcinoma and Treated With Sunitinib at the Nairobi Max Access Solutions Clinic

dc.contributor.author	Nyandika, Douglas
dc.date.accessioned	2026-01-09T12:28:54Z
dc.date.available	2026-01-09T12:28:54Z
dc.date.issued	2024
dc.identifier.uri	http://erepository.uonbi.ac.ke/handle/11295/167911
dc.description.abstract	Background. Sunitinib Was Approved in 2006 as Standard Therapy for Metastatic Renal Cell Carcinoma..............................	en_US
dc.language.iso	en	en_US
dc.publisher	University of Nairobi	en_US
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.title	Clincal Outcomes Ans Assessment Of Quality of Life of Patients Diagnosed With Metastatic Renal Cell Carcinoma and Treated With Sunitinib at the Nairobi Max Access Solutions Clinic	en_US
dc.type	Thesis	en_US
dc.description.department	a Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine, Moi University, Eldoret, Kenya

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States